Synergy Pharmaceuticals Inc (NASDAQ: SGYP) looked like it was headed for a rough start this morning. After starting the pre-market trading off in the red, the company released a PR about an hour ago, leading to excitement and allowing for a recovery to the green. In the release, the company focused on an announcement of … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) is having a relatively strong start in the pre-market hours this morning, and for good reason. The company announced the sale of exclusive rights to its flagship product in the Canadian territory, which is leading to excitement among investors and sending the stock toward the top. Today, we’ll talk about the … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company made an announcement about an hour ago that it has achieved a key cash balance requirement which provides the company access to additional capital. Today, we’ll talk about the story, what we’re seeing … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) is having an incredibly strong day in the market today, and for good reason. In a press release issued early this morning, the company updated investors with regard to a new FDA approval. Today, we’ll talk about the approval, what we’re seeing from the stock, and what we’ll be watching for … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) had a rough day in the market yesterday, falling more than 10% throughout the day and closing down more than 6%. However, today the stock seems to be making a recovery in the pre-market hours. Today, we’ll talk about what we’re seeing from SGYP, the story surrounding the stock, and … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) is having an overwhelmingly rough day in the market today as investors weigh the pros and cons. The reality is that there’s a compelling argument that can be made on both sides. Today, we’ll talk about the bullish argument, the bearish argument, what we’re seeing from the stock, and what … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) is having an overwhelmingly strong start in the pre-market trading hours this morning, and for good reason. The company reported its earnings for the third quarter, beating expectations and exciting investors. Today, we’ll talk about what we saw from earnings, how the stock reacted to the news, and what we’ll … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) is having a bit of a rough time in the market as of late. In fact, the stock has been declining for several consecutive trading sessions, falling from $3.46 on October 6th to under $3 per share today. While the declines may be a bit scary to some investors, chances … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) is having an incredibly strong start to the trading session this morning. At the moment, investors seem to be noticing that the stock is undervalued and deserves to fly, especially considering the fact that the gastrointestinal market is expected to expand in a big way. Before we get into the … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) is off to a relatively strong day in the market thus far this morning after the company announced that it has secured a large chunk of financing. This will not only help the company with the commercialization of plecanatide, but it will also help to make it through to the … Read more